Natural Biocon India schedules board meeting for April 30, 2026, to approve FY26 and Q4 financial results.
Agenda includes consideration of audited financial statements and auditor's report as per SEBI LODR Regulation 33.
Meeting will also address related party transactions and any other business permitted by the chairman.